Cities for Better Health Childhood Obesity Prevention Initiative
This research project is part of the 'Cities for Better Health Childhood Obesity Prevention Initiative' (CBH COPI). The objective of the CBH COPI initiative is to develop, implement, and evaluate the effectiveness of a package of prevention interventions in five cities to promote healthy eating, physical activity, a positive health-related quality of life, and a reduction in rates living with overweight or obesity among children aged 6-13 years in six cities across Australia, Brazil, Canada, Japan, South Africa and Spain. The primary research objective of CBH COPI is to estimate the impact of the intervention packages on the average BMI of the target population of children across the participating countries, at one-year and two-year follow-ups.
The secondary research objective is to estimate the impact of the intervention packages on average health-related quality of life (HRQoL) at the same time points. Exploratory aims include estimating the impact of the packages on behaviours related to physical activity and diet.
Study details:
Requirements for interventions:. The interventions in each country will be multi-level multi-component (MLMC) community-based packages. Their exact features will be tailored to the needs and opportunities of each participating country.
Requirements for study design:. The minimum evaluation study design in terms of robustness is a repeated cross-sectional study with a comparison group. This involves measuring outcomes in a cross-section of children living in the intervention areas of a participating city (i.
e. the areas in which the CBH COPI interventions were implemented) and a cross-section of children in similar comparison areas in which the interventions were not implemented, before and after the interventions are introduced. The global analysis will then compare trends in outcomes between intervention- and comparison-group areas.
Countries are allowed to implement more robust designs (e. g. incorporating randomisation) if this is feasible.
Each country-level study will collect a set of prespecified indicators at baseline and at two subsequent follow-ups (after 10-12 months, and after 20-24 months). The primary outcome indicator is BMI z-score and the required secondary and exploratory outcomes are defined above. A list of sociodemographic indicators (age, sex, ethnicity, household affluence) is also required to be collected (unless this is not feasible in an individual country for legal reasons).
It is anticipated that 2,000 children in the target population will be recruited per data collection point (baseline, first follow-up, second follow-up) in each country. It is recommended (as the default option) that data are collected from 20 'clusters' (schools) from at least 10 'neighbourhoods' (administrative areas or school catchment areas, depending on the country) over these time points. This set up gives a minimum detectable effect size of Cohen's d = 0.
15 in country-level analyses. The sample of neighbourhoods/clusters will be chosen according to feasibility and representativeness considerations in each country. Local evaluations will be adapted to fit with the social, cultural and policy landscape of each implementing site.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
- Informed consent obtained by the child's parent or legal guardian before any study-related activities.
- Aged 6-13 years (both 6 and 13 allowed) at the time of signing consent.
Exclusion criteria
- Children will be excluded from the study if their parent(s) do not provide fully informed consent for their data to be collected.
- If during the measurement day they do not agree to participate.
- If the child's parent(s) or legal guardian(s) withdraw their consent for their child participating in the research at any point.
Eligibility
Age eligible for study : NA
Healthy volunteers accepted : No
Gender eligible for study: ALL
Things to know
Study dates
Study start:
Primary completion:
Study completion finish:
Study type
PREVENTION
Phase
- NA
Study ID
NCT06855563
Intervention or treatment
BEHAVIORAL: Community-based intervention packages
Conditions
- Obesity
You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.
Research sites nearby
Closest Location:
Novo Nordisk Investigational Site
Select from list below to view details:
Novo Nordisk Investigational Site
Loagan, Australia
Loading map...
Who is running the clinical trial?
Novo Nordisk A/S
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
| Participant Group/Arm | Intervention/Treatment |
|---|---|
EXPERIMENTAL: Intervention group
| Behavioral: Community-based intervention packages |
NO_INTERVENTION: Comparison group
|
What is the study measuring?
Primary Outcome
| Measure | Description | Time Frame |
|---|---|---|
| Body mass index z-score (BMI-z) adjusted for age and sex | z-score | At baseline, 1st follow-up (10-12 months) and 2nd follow-up (20-24 months) |
Secondary Outcome
| Measure | Description | Time Frame |
|---|---|---|
| Health-related quality of life (HRQoL), proxied by KIDSCREEN-10 index | Constructed from KIDSCREEN-10 survey. Each of the 10 measures is coded from 1-5. Sum across 10 measures to create a total score (10-50) and linearly rescale to 0-100 for interpretation. | At baseline, 1st follow-up (10-12 months) and 2nd follow-up (20-24 months) |
References
Clinical Trials Gov: Cities for Better Health Childhood Obesity Prevention InitiativeOther trials to consider
Loading suggested trials...
